homovanillic acid has been researched along with Hallucination of Body Sensation in 16 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An open-label study was performed to investigate the clinical efficacy and mechanisms of risperidone liquid in ameliorating positive symptoms in the acute phase of schizophrenia." | 9.11 | An open study of risperidone liquid in the acute phase of schizophrenia. ( Egami, H; Goto, M; Kaji, K; Kakihara, S; Kohara, K; Maeda, H; Nakamura, J; Ninomiya, H; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R, 2005) |
| "In the patient group with visual hallucinations, mean salsolinol level was significantly increased to almost the 3-fold of those found in patients without hallucinations." | 5.29 | Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease. ( Jaskowski, P; Kömpf, D; Moser, A; Siebecker, F; Vieregge, P, 1996) |
| "An open-label study was performed to investigate the clinical efficacy and mechanisms of risperidone liquid in ameliorating positive symptoms in the acute phase of schizophrenia." | 5.11 | An open study of risperidone liquid in the acute phase of schizophrenia. ( Egami, H; Goto, M; Kaji, K; Kakihara, S; Kohara, K; Maeda, H; Nakamura, J; Ninomiya, H; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R, 2005) |
| "CSF levels of radioreceptorassayed endorphins Fraction I (EndFI, n = 92) and homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) (n = 118) were measured in patients with major depressive disorders according to Research Diagnostic Criteria (18% were psychotic; 11% hallucinated during the peak of the depressive episode)." | 3.67 | Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices. ( Agren, H; Terenius, L, 1985) |
| "26 patients with a paranoid-hallucinatory syndrome were treated with a fixed daily dose of haloperidol." | 3.65 | Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol. ( Ackenheil, M; Eben, E; Hippius, H; Rüther, E; Schilkrut, R, 1976) |
| "Patients with the Lewy body variant of Alzheimer's disease tended to experience more frequent extrapyramidal side effects of neuroleptics than did the patients with Alzheimer's disease, but for patients in the two groups who were not exposed to neuroleptics, there was little difference in frequency of extrapyramidal side effects." | 1.29 | Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. ( Cullum, CM; Honig, L; Risser, RC; Rosenberg, RN; Speciale, S; Weiner, MF; White, C, 1996) |
| "In the patient group with visual hallucinations, mean salsolinol level was significantly increased to almost the 3-fold of those found in patients without hallucinations." | 1.29 | Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease. ( Jaskowski, P; Kömpf, D; Moser, A; Siebecker, F; Vieregge, P, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (37.50) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, KM | 1 |
| Gupta, M | 1 |
| Pearl, PL | 1 |
| Tuchman, M | 1 |
| Vezina, LG | 1 |
| Snead, OC | 1 |
| Smit, LM | 1 |
| Jakobs, C | 1 |
| Yoshimura, R | 1 |
| Nakamura, J | 1 |
| Shinkai, K | 1 |
| Goto, M | 1 |
| Yamada, Y | 1 |
| Kaji, K | 1 |
| Kakihara, S | 1 |
| Ueda, N | 1 |
| Kohara, K | 1 |
| Ninomiya, H | 1 |
| Egami, H | 1 |
| Maeda, H | 1 |
| Dávila, R | 1 |
| Zumárraga, M | 1 |
| Basterreche, N | 1 |
| Arrúe, A | 1 |
| Anguiano, JB | 1 |
| Fukuda, M | 1 |
| Niwa, SI | 1 |
| Kumagai, N | 1 |
| Nagakubo, S | 1 |
| Shirayama, Y | 1 |
| Hashimoto, O | 1 |
| Hata, A | 1 |
| Kameyama, T | 1 |
| Anzai, N | 1 |
| Weiner, MF | 1 |
| Risser, RC | 1 |
| Cullum, CM | 1 |
| Honig, L | 1 |
| White, C | 1 |
| Speciale, S | 1 |
| Rosenberg, RN | 1 |
| Yui, K | 1 |
| Goto, K | 1 |
| Ikemoto, S | 1 |
| Ishiguro, T | 1 |
| Moser, A | 1 |
| Siebecker, F | 1 |
| Vieregge, P | 1 |
| Jaskowski, P | 1 |
| Kömpf, D | 1 |
| Billiard, M | 1 |
| Guilleminault, C | 1 |
| Dement, WC | 1 |
| Pieri, L | 1 |
| Keller, HH | 1 |
| Burkard, W | 1 |
| Da Prada, M | 1 |
| Rüther, E | 2 |
| Schilkrut, R | 2 |
| Ackenheil, M | 2 |
| Eben, E | 2 |
| Hippius, H | 2 |
| Migály, P | 1 |
| Perry, EK | 2 |
| Marshall, E | 2 |
| Kerwin, J | 2 |
| Smith, CJ | 1 |
| Jabeen, S | 2 |
| Cheng, AV | 1 |
| Perry, RH | 1 |
| McKeith, I | 1 |
| Thompson, P | 1 |
| Edwardson, JA | 1 |
| Ince, P | 1 |
| Blessed, G | 1 |
| Irving, D | 1 |
| Agren, H | 1 |
| Terenius, L | 1 |
| Angrist, B | 1 |
| Sathananthan, G | 1 |
| Wilk, S | 1 |
| Gershon, S | 1 |
2 trials available for homovanillic acid and Hallucination of Body Sensation
| Article | Year |
|---|---|
An open study of risperidone liquid in the acute phase of schizophrenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Chromatography, High Pressure Liquid; | 2005 |
Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks.
Topics: Adult; Antipsychotic Agents; Dopamine; Female; Hallucinations; Homovanillic Acid; Humans; Methamphet | 1996 |
14 other studies available for homovanillic acid and Hallucination of Body Sensation
| Article | Year |
|---|---|
Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).
Topics: Adult; Aldehyde Oxidoreductases; Atrophy; Cerebellum; Chromatography, High Pressure Liquid; Chromato | 2003 |
Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
Topics: Adolescent; Adult; Antipsychotic Agents; Depression; Dopamine; Female; Hallucinations; Haloperidol; | 2007 |
Compensatory function of central dopaminergic system for suppressing psychic seizures--repeated plasma homovanillic acid measurement in refractory temporal lobe epilepsy.
Topics: Adult; Chromatography, High Pressure Liquid; Epilepsy, Temporal Lobe; Female; Hallucinations; Homova | 1993 |
Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Height; Delusions; Diagn | 1996 |
Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Biomarkers; Catecholamines; Female; Hallucinations | 1996 |
A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity?
Topics: Adolescent; Disorders of Excessive Somnolence; Electroencephalography; Estrogens, Conjugated (USP); | 1975 |
Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
Topics: Animals; Brain; Cyclic AMP; Dopamine; Ergolines; Hallucinations; Homovanillic Acid; Humans; Hydroxyi | 1978 |
Clinical and biochemical parameters during neuroleptic treatment. I. Investigations with haloperidol.
Topics: Adult; Female; Hallucinations; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mal | 1976 |
Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
Topics: Adult; Aged; Brain Damage, Chronic; Depression; Female; Hallucinations; Haloperidol; Homovanillic Ac | 1976 |
Hallucination, dopamine and hypnotizability.
Topics: Dopamine; Hallucinations; Homovanillic Acid; Humans; Hypnosis; Suggestion | 1992 |
Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
Topics: Acetylcholine; Aged; Aged, 80 and over; Autopsy; Biogenic Amines; Choline O-Acetyltransferase; Demen | 1990 |
Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Cerebral Cortex; Choline O-Acetyltransferase; Dementia; Hallucinatio | 1991 |
Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices.
Topics: Adult; Age Factors; Bipolar Disorder; Depressive Disorder; Endorphins; Female; Hallucinations; Homov | 1985 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depressio | 1974 |